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and SSI-1 (STAT induced STAT inhibitor-1) (Endo et al.,
1997; Naka et al., 1997; Starr et al., 1997). For reasons
of simplicity, we will use the SOCS nomenclature in this
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review. Sequence searching in public databases hasCollege of Physicians and Surgeons
revealed six other family members that have a centralColumbia University
SH2 domain and a C-terminal SOCS box. The N-terminalNew York, New York 10032
regions of these proteins are highly variable (Figure 1).
Table 1 summarizes different nomenclatures that have
been used in the literature for these proteins. In addition
The growth, differentiation, and function of hematopoi- to the SH2-containing members, there are at least a
etic cells are controlled by the coordinated action of dozen other proteins that share the SOCS box motif but
the cytokine network. The pathways by which cytokines not the SH2 domain (Hilton et al., 1998). Instead, these
exert their biologic effects have been under intensive proteins possess other domains that can potentially
investigation over the past few years. As most cytokine mediate protein-protein interactions. Together, these
receptors lack a cytoplasmic kinase domain, ligand- twenty proteins form a superfamily of proteins that may
dependent tyrosine phosphorylation is mediated by require the SOCS box for their function. The non-SH2-
nonreceptor tyrosine kinases. The major tyrosine ki- containing proteins can be further divided into several
nases activated immediately following cytokine stimula- subfamilies: WSB for WD-40-repeat-containing pro-
tion are the Janus kinase (JAK) family. In fact, the JAK- teins, SSB for SPRY domain-containing proteins, and
STAT pathway is one of the most important mechanisms ASB for ankyrin-repeat-containing proteins. In addition,
by which many cytokines activate gene transcription. there are two small GTPases and two ESTs of unknown
When cytokines bind to receptors on the cell surface, structural class that contain the SOCS box motif
they cause receptor oligomerization, which in turn in- (Figure 1).
duces JAK kinase activation. The activated JAK kinases,
in turn, phosphorylate the cytokine receptors, leading CIS: Prototype of the SOCS Family Proteins
to the recruitment and subsequent activation of other The first member of the SOCS family was identified as
signaling molecules such as the STAT family proteins. an immediate early gene induced in response to several
The activated STAT proteins translocate into the nucleus cytokines (Yoshimura et al., 1995). It was denoted as
and activate transcription of a range of cytokine respon- CIS for cytokine-inducible SH2-containing protein. CIS
sive genes. has been shown to bind to phosphorylated tyrosines on
Although it is clear that the effect of most cytokines is multiple cytokine receptors. In vitro and in vivo studies
limited in both magnitude and duration, the mechanisms support a role for CIS as a negative regulator of STAT5
underlying this regulation are not well understood. The activation in response to several cytokines, including
most important limitation of cytokine activity occurs EPO, IL-2, and IL-3 (for review, see Yasukawa et al.,
through regulated production of the cytokine itself. In 2000). One mechanism by which CIS may inhibit cyto-
addition, several other mechanisms have been demon- kine signaling is by competing for Stat5 binding sites
strated to control responsiveness to cytokines. Among on the activated receptors and thus preventing recruit-
these, selective expression of cytokine receptors has ment of Stat5 to the receptors (Figure 2). Alternatively,
been well documented as an effective way to regulate CIS may function as an adaptor protein linking cytokine
cytokine responsiveness. In addition, more complex receptors and other negative regulators. Matsumoto et
regulation exists inside the cells, where signals from al. (1999) generated transgenic mice expressing CIS un-
multiple stimuli converge. Intracellular regulation can der control of the b-actin promoter. Mice overexpressing
occur on the receptor at the plasma membrane, in the CIS are smaller in body size, suggesting defects in
cytoplasm, and in the nucleus. Tyrosine phosphatases growth-hormone signaling. Female mice also manifest
have been reported to modulate signaling by dephos- defects in the development of mammary glands, most
phorylation of signaling proteins. The PIAS family of likely due to inhibition of prolactin signaling. Further-
proteins has also been implicated in the negative regula- more, IL-2 induced activation of STAT5 is markedly in-
tion of STAT function (for review, see Yasukawa et al., hibited in T cells from CIS-transgenic mice, while leuke-
2000). mia inhibitory factor induced STAT3 phosphorylation
is not affected. These data indicate a certain level of
Identification of the SOCS Family Proteins specificity underlying CIS-mediated inhibition of cyto-
Recently, a new family of proteins has been identified kine signaling.
as negative inhibitors of cytokine signaling. The first Besides cytokines, CIS is also induced by TCR stimu-
member of the family, CIS, was identified as an immedi- lation in T cells (Li et al., 2000). In the transgenic mice
ate early gene induced by multiple cytokines (Yoshimura with CIS under control of the b-actin promoter, the num-
et al., 1995). The second family member, which can bers of gd T cells and natural killer (NK) cells are drasti-
inhibit JAK kinases, was identified independently by cally reduced. In addition, differentiation of Th1/Th2
three groups. The same protein was given three different cells is also altered (Matsumoto et al., 1999). The mecha-
names denoting how it was identified: SOCS-1 (suppres- nisms underlying these abnormalities are not clear. To
sor of cytokine signaling-1), JAB (JAK binding protein), investigate the specific role of CIS in the T cell lineage,
transgenic mice selectively overexpressing CIS in CD41
T cells were created (Li et al., 2000). Forced expression* E-mail: pbr3@columbia.edu.
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Figure 2. Negative Regulation of Cytokine Signaling by SOCS Pro-
teins
Transcription of some SOCS family genes is activated upon cytokine
stimulation, which is possibly mediated by the STAT family of tran-
scription factors. Two mechanisms have been proposed for how
SOCS proteins, in turn, suppress cytokine signaling: (1) SOCS pro-
teins (e.g., CIS) may bind to phosphorylated tyrosines (represented
by a series of pYs) on the cytokine receptors and block recruitment
Figure 1. Domain Structure of the SOCS Superfamily Proteins and activation of downstream molecules (e.g., STATs); and (2) SOCS
The SOCS superfamily can be divided into two subfamilies: the SH2- proteins (e.g., SOCS-1) may suppress cytokine signaling by binding
containing and the non-SH2-containing SOCS proteins. The former, and inhibiting tyrosine kinases (e.g., JAK) that are essential for cyto-
consisting of CIS and SOCS-1 through SOCS-7, all contain a central kine signaling.
SH2 domain in addition to a C-terminal SOCS box. Members of the
other family contain the SOCS box and protein domains other than
SH2 domain and can thus be grouped into several subfamilies based has also been shown to suppress Tec kinase, as well
on the domains that they possess: ASB, ankyrin-repeat-containing
as signaling downstream of receptor tyrosine kinasesproteins; WSB, WD-40-containing proteins; SSB, SPRY-domain-
(for review, see Yasukawa et al., 2000). De Sepulvedacontaining proteins; Ras-like GTPases contain a GTPase domain.
et al. (2000) have recently reported that SOCS-1 may
inhibit Vav function and suppress c-kit-mediated prolif-
eration induced by steel factor. As SOCS-1 protein levelsof CIS promotes TCR-mediated proliferation and pro-
appear to be tightly regulated, however, these observa-longs survival of CD41 T cells after TCR stimulation. The
tions using overexpression systems should be interpre-authors proposed that CIS may exert these effects by
ted cautiously.regulating MAP kinase activation. Analysis of the CIS
null mice will be needed to determine the physiologic
role of CIS in cytokine signaling and T cell activation. Lessons from the SOCS-1 Null Mice
SOCS-1 mRNA is present at the highest levels in the
thymus and spleen (Starr et al., 1997; Marine et al.,SOCS-1 Inhibits Multiple Signaling Pathways In Vitro
1999b), suggesting a role for SOCS-1 in the immuneSOCS-1 was initially identified as an inhibitor of IL-6
system. To investigate the physiological role of SOCS-1,induced differentiation of murine monocytic leukemic
mice lacking the SOCS-1 gene have been generatedM1 cells, as a JAK binding protein, and as a protein with
by several groups. The SOCS-1-deficient mice displayan SH2 domain similar to that of STAT proteins (Endo
growth retardation and die within 3 weeks of birth withet al., 1997; Naka et al., 1997; Starr et al., 1997). Indeed,
fatty degeneration of the liver and monocytic infiltrationSOCS-1 has been shown to bind to all four JAK kinases
of several organs. The thymus of these mice is markedlythrough its central SH2 domain and to inhibit their kinase
smaller than those of wild-type littermates. Lympho-activity in vitro. When the SOCS-1 protein is overex-
cytes from the SOCS-12/2 mice undergo acceleratedpressed in cell lines, it can inhibit STAT activation in-
apoptosis associated with increased levels of the pro-duced by several cytokines, including interferons, IL-6,
apoptotic protein Bax (Naka et al., 1998). In addition,IL-4, and LIF (for review, see Yasukawa et al., 2000)
these mice exhibited a progressive loss of maturing B(Figure 2). In addition to inhibiting JAK kinases, SOCS-1
lymphocytes in the bone marrow, spleen, and peripheral
blood (Naka et al., 1998; Starr et al., 1998). More recently,
Morita et al. (2000) have demonstrated that murine em-
Table 1. List of SH2-Containing SOCS Family Members
bryonic fibroblasts lacking SOCS-1 are more sensitive
Nomenclature to TNFa induced cell death, providing a possible mecha-
in This Review Other Names Cellular Target nism for the increased apoptosis in SOCS-1-deficient
lymphocytes.CIS CIS1 cytokine receptors, EPO, etc
The pathology caused by disruption of SOCS-1 isSOCS-1 JAB (SSI-1) JAK kinases
SOCS-2 CIS2 (SSI-2) IGF-I receptor? similar to that seen in wild-type mice subjected to daily
SOCS-3 CIS3 (SSI-3) JAK kinases, cytokine receptors? administration of IFNg from birth. This observation
SOCS-4 CIS7 ? prompted two groups to generate mice lacking both
SOCS-5 CIS6 ? the SOCS-1 and IFNg genes. The complex diseases
SOCS-6 CIS4 ? observed in the SOCS-12/2 mice are eliminated in mice
SOCS-7 CIS5 (NAP4) Nck, Ash and phospholipase g?
deficient in both SOCS-1 and IFNg (Alexander et al.,
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1999; Marine et al., 1999b). In addition, SOCS-12/2 mice kinase inhibitory region) also contribute to high-affinity
binding to the kinase domain and are indispensable forare hyperresponsive to viral infection and yield macro-
phages with an enhanced IFNg-dependent capacity to inhibition of JAK kinase activity (Nicholson et al., 1999;
Yasukawa et al., 1999). Yasukawa et al. (1999) proposedkill L. major parasites (Alexander et al., 1999). Taken
together, these data suggest that SOCS-1 is a critical that the kinase inhibitory region of SOCS-1 may mimic
the activation loop of JAK and act as a pseudosubstrate.regulator of cellular sensitivity to IFNg, balancing the
beneficial immunological function with the potentially Thus, SOCS-1 appears to inhibit JAK kinase activity by
binding to the activation loop and preventing the accesslethal effects of IFNg. Intriguingly, lymphoid stem cells
from mice lacking SOCS-1 can confer this lethality to of substrates and/or ATP to the catalytic pocket. Al-
though neither the N-terminal 50 amino acids nor thesublethally irradiated JAK3-deficient mice (Marine et al.,
1999b). Since the recipient mice are otherwise normal C-terminal SOCS box is required for inhibition of JAK
kinase activity in these in vitro studies, these domainsexcept for defects in the lymphoid lineage, this experi-
ment demonstrates that the lethality in SOCS-1-defi- may be important for the in vivo function of SOCS-1.
cient mice can be mediated by lymphocytes on a back-
ground in which the SOCS-1 gene is present in other Regulation of SOCS-1 Levels and the Role
cell types. Furthermore, introducing RAG2 deficiency of the SOCS Box
into the SOCS-1 null mice can rescue the lethality Expression of SOCS-1 protein appears to be controlled
caused by SOCS-1 deficiency (Marine et al., 1999b). at both the transcriptional and posttranscriptional lev-
These results suggest a critical role of lymphocytes in els. mRNA levels of SOCS-1 have been shown to be
causing the lethality. The mechanism by which the increased upon cytokine stimulation (Starr et al., 1997;
SOCS-1-deficient lymphoid cells exert the lethal effect Naka et al., 1997). In fact, the promoter region of SOCS-1
is still unknown. It has been postulated that loss of contains binding sequences for Stat3 and Stat6 (Naka
SOCS-1 may result in aberrant development of T or NK et al., 1997). Moreover, Marine et al. (1999b) have sug-
cells, which then produce excessive amounts of IFNg gested that the expression of SOCS-1 in thymocytes is
and cause lethality. One prediction from this model is also developmentally regulated. More interestingly, the
that the serum levels of IFNg are higher in SOCS-1- levels of SOCS-1 appears to be controlled by modulation
deficient mice than in wild-type littermates. However, it of its protein stability. Narazaki et al. (1998) first reported
remains controversial whether the serum levels of IFNg that deletion of the SOCS box decreased the expression
are elevated in SOCS-1-deficient mice (Alexander et al., level of SOCS-1 protein in M1 cells, suggesting that the
1999; Marine et al., 1999b). This contradiction may result SOCS box may protect the protein from degradation.
from variations in mouse strains or the reagents used More recently, two groups have independently identified
to detect IFNg. Elongin BC as binding partner of the SOCS box (Kamura
In summary, the available data suggest that SOCS-1 et al., 1998; Zhang et al., 1999). In one report, it was
may have two essential functions that, when disrupted, demonstrated that cotransfection of Elongin BC stabi-
result in perinatal lethality. One role of SOCS-1 may be lizes SOCS-1 in 293T cells (Kamura et al., 1998). In the
to regulate T cell differentiation and function. The other other report, Zhang et al. (1999) suggested that binding
role may be to modulate responsiveness to IFNg in both of Elongin BC may target SOCS proteins (along with their
lymphoid and nonlymphoid cells. More studies are binding partners) to the proteasome for degradation.
necessary to understand the precise mechanism by Interestingly, the SOCS box motif that binds to Elongin
which SOCS-1 protein exerts these effects. Although BC structurally resembles the a domain of the von Hip-
SOCS-12/2 mice show few phenotypes associated with pel-Lindau (VHL) tumor-suppressor gene product and
altered signaling by other cytokines, it is possible that the F box proteins. Both VHL and the F box proteins
some defects may only manifest themselves late in life have been shown to be part of cellular complexes con-
or only under certain circumstances. Indeed, a role for sisting of Elongin BC, Cullins, and Rbx1 (for review, see
SOCS-1 as a negative regulator of IL-4 signaling has Yasukawa et al., 2000). Rbx1 is a ring-finger-containing
been suggested based on observations that IL-4 in- protein that is conserved from yeast to human. The yeast
duced Stat6 activation is prolonged in SOCS-1-deficient homolog of Rbx1 has been shown to be a key compo-
mice (Naka et al., 1998). More detailed analysis of these nent of the ubiquitin ligase E3 complex. It is therefore
mice will be needed to clarify the in vivo function of possible that SOCS-1, by binding to the activated JAK
SOCS-1 in other cytokine signaling pathways, as well kinases, may target JAK to the proteasome in an Elongin
as in the cross-regulation of different cytokines. BC–dependent manner. Thus, interaction with Elongin
BC may not only control the levels of SOCS-1 protein
but may also contribute to SOCS-1 function.Molecular Mechanism of Kinase Inhibition
by SOCS-1
SOCS-1 has been shown to bind to and inhibit all four Other SOCS Family Members
In addition to CIS and SOCS-1, SOCS-3 is another familyJAK kinases (Figure 2). JAK kinases are activated
through transphosphorylation of a critical tyrosine within member that has been shown to suppress cytokine sig-
naling. The mechanism by which SOCS-3 inhibit cyto-the activation loop, and SOCS-1 has been shown to
bind to this phosphorylated tyrosine in an SH2 domain– kine induced STAT activation is not completely under-
stood. Although SOCS-3 can bind to JAK kinases, it failsdependent manner. Extensive mutational analysis has
revealed that 12 amino acids N-terminal to the SH2 do- to inhibit JAK kinase activity in vitro. Moreover, mutation
of the arginine in the conserved FLVRDS motif withinmain (extended SH2 subdomain) of SOCS-1 are required
for binding to the activation loop of JAKs. The extended the SH2 domain of SOCS-3 does not abolish its ability
to inhibit LIF-induced STAT activation (Nicholson et al.,SH2 subdomains are conserved among the SOCS family
members and the STATs. An additional 12 amino acids 1999). SOCS-3 mRNA is induced by a number of cyto-
kines, and overexpression studies have implicatedN-terminal to the extended SH2 subdomain (termed the
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T.A., Sprigg, N.S., Starr, R., Nicholson, S.E., Metcalf, D., and Nicola,SOCS-3 in the signaling of growth hormone, leptin,
N.A. (1998). Proc. Natl. Acad. Sci. USA 95, 114–119.CNTF, and IL-2 (for review, see Yasukawa et al., 2000).
Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W.G., Jr., Conaway,Marine et al. (1999a) used transgenic and gene disrup-
R.C., and Conaway, J.W. (1998). Genes Dev. 12, 3872–3881.tion approaches to investigate the role of SOCS-3 in
Li, S., Chen, S., Xu, X., Sundstedt, A., Paulsson, K.M., Anderson,vivo. Disruption of SOCS-3 gene results in embryonic
P., Karlsson, S., Sjogren, H.O., and Wang, P. (2000). J. Exp. Med.lethality at 12–16 days associated with marked erythro-
191, 985–994.cytosis. These results indicate that, while SOCS-3 is not
Marine, J.C., McKay, C., Wang, D., Topham, D.J., Parganas, E.,absolutely required for bone marrow erythropoiesis and
Nakajima, H., Pendeville, H., Yasukawa, H., Sasaki, A., Yoshimura,normal lymphoid development, it plays an essential role
A., and Ihle, J.N. (1999a). Cell 98, 617–627.during fetal liver erythropoiesis. It is not clear whether
Marine, J.C., Topham, D.J., McKay, C., Wang, D., Parganas, E.,SOCS-3 also plays an essential role in the regulation of
Stravopodis, D., Yoshimura, A., and Ihle, J.N. (1999b). Cell 98,cytokine signaling after birth.
609–616.
SOCS-2-deficient mice have also been generated
Matsumoto, A., Seki, Y., Kubo, M., Ohtsuka, S., Suzuki, A., Hayashi,(Metcalf et al., 2000). Most organs in the SOCS-22/2
I., Tsuji, K., Nakahata, T., Okabe, M., Yamada, S., and Yoshimura,
mice appear normal, and no defects in the hematopoi- A. (1999). Mol. Cell. Biol. 19, 6396–6407.
etic system are observed. Strikingly, the SOCS-2-defi-
Metcalf, D., Greenhalgh, C.J., Viney, E., Willson, T.A., Starr, R., Ni-
cient mice are much larger in body size than their wild- cola, N.A., Hilton, D.J., and Alexander, W.S. (2000). Nature 405,
type littermates. Deregulation of growth hormone and 1069–1073.
insulin-like growth factor-I (IGF-1) signaling is observed Morita, Y., Naka, T., Kawazoe, Y., Fujimoto, M., Narazaki, M., Naka-
in the SOCS-22/2 mice, suggesting a possible role for gawa, R., Fukuyama, H., Nagata, S., and Kishimoto, T. (2000). Proc.
SOCS-2 in regulating signaling by these two cytokines Natl. Acad. Sci. USA 97, 5405–5410.
during postnatal growth. There have been scant reports Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S.,
on the function of other SOCS family members. SOCS-5 Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al.
mRNA is expressed in many tissues and is induced by (1997). Nature 387, 924–929.
IL-6 in the liver (Hilton et al., 1998). SOCS-7 (also termed Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y.,
NAP4) has been shown to bind to Nck, Ash (Grb2), and Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y., and Kishimoto,
T. (1998). Proc. Natl. Acad. Sci. USA 95, 15577–15582.phospholipase g (for review, see Yasukawa et al., 2000).
Narazaki, M., Fujimoto, M., Matsumoto, T., Morita, Y., Saito, H.,
Kajita, T., Yoshizaki, K., Naka, T., and Kishimoto, T. (1998). Proc.Summary and Perspectives
Natl. Acad. Sci. USA 95, 13130–13134.
The mechanism by which cytokine signaling is regulated
Nicholson, S.E., Willson, T.A., Farley, A., Starr, R., Zhang, J.G., Baca,has been a focus of research in the past few years.
M., Alexander, W.S., Metcalf, D., Hilton, D.J., and Nicola, N.A. (1999).
The SOCS family proteins have recently emerged as EMBO J. 18, 375–385.
important regulators of cytokine signaling. Although the
Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jen-
first two family members, CIS and SOCS-1, were identi- kins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A.,
fied as cytokine-inducible inhibitors of JAK-STAT activa- and Hilton, D.J. (1997). Nature 387, 917–921.
tion, it is not clear whether other family members also Starr, R., Metcalf, D., Elefanty, A.G., Brysha, M., Willson, T.A., Nicola,
act similarly. Gene disruption experiments have sug- N.A., Hilton, D.J., and Alexander, W.S. (1998). Proc. Natl. Acad. Sci.
gested a critical role for SOCS-1 in the regulation of USA 95, 14395–14399.
IFNg signaling and T cell development. SOCS-2 and Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A.,
SOCS-3 have also been shown to be important in post- Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J.N., and
natal growth and in fetal liver erythropoiesis, respec- Yoshimura, A. (1999). EMBO J. 18, 1309–1320.
tively. The precise mechanisms by which these proteins Yasukawa, H., Sasaki, A., and Yoshimura, A. (2000). Annu. Rev.
exert their effects remain to be determined. In addition, Immunol. 18, 143–164.
the function of the conserved SOCS box will be another Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N.A., Gilbert, D.J.,
focus of research. Although the SOCS box has been Copeland, N.G., Hara, T., and Miyajima, A. (1995). EMBO J. 14,
2816–2826.proposed to be involved in the ubiquitylation of proteins,
there has been no direct evidence supporting a role for Zhang, J.G., Farley, A., Nicholson, S.E., Willson, T.A., Zugaro, L.M.,
Simpson, R.J., Moritz, R.L., Cary, D., Richardson, R., Hausmann,SOCS proteins in cellular ubiquitylation. Overall, identifi-
G., et al. (1999). Proc. Natl. Acad. Sci. USA 96, 2071–2076.cation of the SOCS family has opened a new field of
research in signal transduction. Studies of these pro-
teins will not only increase our understanding of immune
regulation by the cytokine network but may also lead
to development of specific pharmacological inhibitors
of cytokine signaling.
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